Cargando…

Digestive system infection by SARS-CoV-2: Entry mechanism, clinical symptoms and expression of major receptors (Review)

Besides causing severe acute respiratory syndrome (SARS), SARS-coronavirus 2 (SARS-CoV-2) also harms the digestive system. Given the appearance of numerous cases of SARS-CoV-2, it has been demonstrated that SARS-CoV-2 is able to harm target organs such as the gastrointestinal tract, liver and pancre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Liming, Zhang, Li, Zheng, Yi, An, Jiaxing, Wen, Guorong, Jin, Hai, Tuo, Biguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911086/ https://www.ncbi.nlm.nih.gov/pubmed/36660939 http://dx.doi.org/10.3892/ijmm.2023.5222

Ejemplares similares

Pathology and physiology of acid-sensitive ion channels in the digestive system (Review)
por: Zhang, Li, et al.
Publicado: (2022)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

APOBEC3B: Future direction of liver cancer research
por: Yang, Xingyue, et al.
Publicado: (2022)

A potential tumor marker: Chaperonin containing TCP-1 controls the development of malignant tumors (Review)
por: Zheng, Liming, et al.
Publicado: (2023)

Physiological and pathological roles of Hic-5 in several organs (Review)
por: Yao, Shun, et al.
Publicado: (2022)

The source of the fat significantly affects the results of high-fat diet intervention
por: An, Jiaxing, et al.
Publicado: (2022)

Receptors and Cofactors That Contribute to SARS-CoV-2 Entry: Can Skin Be an Alternative Route of Entry?
por: Barthe, Manon, et al.
Publicado: (2023)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion
por: Xie, Rui, et al.
Publicado: (2019)

Cell entry mechanisms of SARS-CoV-2
por: Shang, Jian, et al.
Publicado: (2020)

SARS-CoV-2, Early Entry Events
por: Chambers, James P., et al.
Publicado: (2020)

Mechanisms of SARS-CoV-2 entry into cells
por: Jackson, Cody B., et al.
Publicado: (2021)

SLC26A9 deficiency causes gastric intraepithelial neoplasia in mice and aggressive gastric cancer in humans
por: Liu, Xuemei, et al.
Publicado: (2022)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Role of Ca(2+) channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review)
por: Chen, Xingyue, et al.
Publicado: (2022)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Surface vimentin is critical for the cell entry of SARS-CoV
por: Yu, Yvonne Ting-Chun, et al.
Publicado: (2016)

Tumor markers as an entry for SARS‐CoV‐2 infection?
por: Xia, Pu, et al.
Publicado: (2020)

Entry, egress and vertical transmission of SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Role of host factors in SARS-CoV-2 entry
por: Evans, John P., et al.
Publicado: (2021)

Contribution of Syndecans to the Cellular Entry of SARS-CoV-2
por: Hudák, Anett, et al.
Publicado: (2021)

Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors
por: Huang, Li, et al.
Publicado: (2022)

Roles of host proteases in the entry of SARS-CoV-2
por: Zabiegala, Alexandria, et al.
Publicado: (2023)

Effect of Common Medications on the Expression of SARS‐CoV‐2 Entry Receptors in Kidney Tissue
por: Saheb Sharif‐Askari, Narjes, et al.
Publicado: (2020)

Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
por: Barker, Harlan, et al.
Publicado: (2020)

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
por: Zamorano Cuervo, Natalia, et al.
Publicado: (2020)

Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue
por: Saheb Sharif-Askari, Narjes, et al.
Publicado: (2020)

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020)

SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain
por: Fodoulian, Leon, et al.
Publicado: (2020)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Major royal jelly proteins elicited suppression of SARS-CoV-2 entry and replication with halting lung injury
por: Abu-Serie, Marwa M., et al.
Publicado: (2023)

Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics
por: Matusiak, Magdalena, et al.
Publicado: (2020)

SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection
por: Trbojević-Akmačić, Irena, et al.
Publicado: (2021)

Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry
por: Zhu, Shiyou, et al.
Publicado: (2021)

LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans
por: Song, Jaewon, et al.
Publicado: (2021)

Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor
por: Fonnesu, Rossella, et al.
Publicado: (2022)

Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry
por: Yoshizato, Katsutoshi, et al.
Publicado: (2022)

Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
por: Yuan, Zixuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iauoturke4sohlkhu8hgk50e7k